Fatal Encephalitis in Young Measles Patient After Stem Cell Transplant Raises Awareness of Vaccination Risks

The New England Journal of Medicine has reported the death of a 21-year-old man who developed fatal brain inflammation after contracting measles following a stem cell transplant.

—

A Case That Stopped Specialists in Their Tracks

He was 21 years old. He’d already been through one of the most gruelling medical journeys a young person can face — an allogeneic stem cell transplant, the kind of procedure where donor cells are used to rebuild a patient’s immune system from scratch. Then measles arrived.

The New England Journal of Medicine, one of the world’s most respected medical publications, posted details of the case on X, formerly Twitter, drawing attention to a sequence of events that clinicians working in transplant medicine will find deeply sobering.

The young man contracted measles after his transplant. His care was already complicated by graft-versus-host disease — a condition where the donated immune cells begin attacking the patient’s own body, as though mistaking it for a foreign invader. He recovered from the acute measles infection itself. But that wasn’t the end.

When Recovery Turns

Encephalitis developed. That’s inflammation of the brain — a condition that can follow certain viral infections and, in vulnerable patients, can be catastrophic. In this case, it was ultimately fatal.

The case is a stark illustration of what measles can do in patients whose immune systems are severely compromised. For most healthy people, measles is a serious but survivable illness. For someone whose immune defences have been deliberately suppressed as part of a transplant procedure, the virus can find far more dangerous pathways through the body.

Allogeneic stem cell transplants — where stem cells come from a donor rather than the patient themselves — are used to treat conditions including leukaemia, lymphoma, and certain inherited blood disorders. The procedure requires the patient’s existing immune system to be largely destroyed before the donor cells are introduced, leaving a window of profound vulnerability that can last months.

Why Measles Remains a Threat

Measles was once thought to be on the path to elimination in the UK. But vaccination rates have dipped in parts of the country over the past decade, and cases have been climbing again. For most of the population, the MMR vaccine — measles, mumps, and rubella — provides reliable protection. But patients who’ve had stem cell transplants often can’t receive live vaccines, at least not immediately after the procedure. They depend on the immunity of those around them.

That dependency is not abstract. It has a name, and a face — a 21-year-old man whose case is now part of the medical record.

According to the New England Journal of Medicine, which published the case report, the progression from measles infection to fatal encephalitis in this patient followed his recovery from the initial acute illness — meaning the danger came after the moment when he might have seemed to be improving.

The Broader Picture

UK Health Security Agency data has previously shown that measles cases in England rose sharply in 2023 and into 2024, with the West Midlands seeing a particular surge. Kent has not been immune to the wider national trend of patchy MMR uptake, with some areas of the county recording vaccination rates below the 95% threshold recommended to maintain herd immunity.

NHS England has repeatedly urged parents to ensure children are up to date with their MMR jabs — two doses are needed for full protection. Adults who are unsure whether they were vaccinated as children can check with their GP.

—

Key Takeaways

• A 21-year-old man died from encephalitis — brain inflammation — after contracting measles following an allogeneic stem cell transplant complicated by graft-versus-host disease, according to the New England Journal of Medicine
• The case highlights the serious risk measles poses to immunocompromised patients, who cannot always receive live vaccines and rely on community immunity for protection
• MMR vaccination rates in parts of Kent fall below the 95% level recommended for herd immunity, leaving vulnerable residents at greater indirect risk

—

What This Means for Kent Residents

If you or someone in your family is due an MMR vaccination — or you’re unsure whether you’ve had both doses — contact your GP surgery to check your records and book an appointment if needed. Kent residents who are currently undergoing, or recovering from, stem cell transplants or other treatments that suppress the immune system should speak to their transplant team about measles exposure risks and what precautions are appropriate for their situation. For general health concerns about measles symptoms, which include high fever, a distinctive blotchy rash, cough, and red eyes, contact NHS 111 online or by phone; in an emergency, always call 999.